Skip to main content
Clinical Trials/NL-OMON46593
NL-OMON46593
Recruiting
Not Applicable

Effects of transcutaneous pulsed radiofrequency on patients with advanced cancer - Transcutaneous pulsed radiofrequency applied to cancer patients

Radboud Universitair Medisch Centrum0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
15
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) \>\= 18 years of age;
  • 2\) patients with advanced\-stage colorectal, breast, prostate or ovarian cancer;
  • 3\) presently no longer responding to systemic treatment, and no other standard oncological treatment can be applied anymore (i.e. a patient is strictly in a clear palliative trajectory).
  • 4\) history of tumor marker corresponding with disease progression on imaging;
  • 5\) history of tumor marker responding to previous oncological treatment;
  • 6\) patients able and willing to give written informed consent and comply with the requirement of the study protocol;
  • 7\) life expectancy at least 3 months.

Exclusion Criteria

  • 1\) treatment with any cancer therapy, including but not limited to chemotherapy and radiation therapy, within 4 weeks before baseline;
  • 2\) in the use of critical measuring devices, large metal implants or active implants like a pacemaker;
  • 3\) pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials